Parakriti Gupta1, Kapil Goyal2 and Mini Pritam Singh3*
Hepatitis E Virus and Zoonosis
...iterature on the role of sofosbuvir also in these groups of patients. Since the virus has only one serotype, univalent vaccine can provide protection against all HEV genotypes. Two vaccine candidates have been evaluated in clinical trials. Among these two vaccine candidates, one has been developed by Glaxosmithkline and another HEV 239 (Hecolin) has been developed by Innovax (China) and is in use in China since 2012. Considering the expanding clinical spectrum...
Gehad M. Mohamed1*; Ahmed B. Barakat1; Marwa M. Gado1; Fatma M. Abdallah2
Novel Research in Microbiology Journal (2024), 8(1): 2320-2338
Saima Younas1*, Quratulain Maqsood1, Aleena Sumrin1, Muhammad Umer Khan2 and Nazim Hussain1
...include the use of DAAs, sofosbuvir (SOF) and daclatasvir (DCV). Current study was designed to analyze treatment efficacy of two different DAA-based regimens in chronic HCV infected people among most recurrent genotypes (GT) of HCV in the patients employing DAAs for the first time (HCV treatment-naive) and in the patients those already experienced interferon (INF) plus ribavirin (RBV) combined treatment (HCV treatment-experienced).For this purpose blood sample...
